Skip to main content

Safir Anand’s views on how a better awareness of their rights will help designers better protect their rights reported in a Business World article on plagiarism in the fashion industry.

Extracts from the article:

Safir Anand, copyright expert, while shedding light on the issue said, “To improve the scenario, it is imperative that the design community engages to understand the scope of rights, the scope of protection, the advantages of protection and the advantages of enforcement.”

He further said that the situation will improve when courts fast track such matters (already under consideration) and encourage to grant exemplary and punitive damages. “Things will also get better if there is a specific legislation that tackles the interest of the fashion industry and does away with the requirement to protect the work before any commercial launch,” he added.

Read more on Business World.

Safir Anand has been invited by the Fashion Design Council of India to its Board of Directors to “help members solve copyright issues”.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on Chambers’ By: Dhruv Anand, Dhananjay Khanna and Bhavya Verma It will not be an exaggeration to say that there has been an explosion

PERSONALITY RIGHTS – CURRENT TRENDS
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on India Business Law Journal’ By: Shantanu Sahay and Pratyush Acharya As India moved towards full implementation of the Digital Personal

Treatment of legacy personal data under the DPDPA
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India